2026-01-28 - Analysis Report
**Company Overview**
Thermo Fisher Scientific Inc. is a leading global biotechnology company.

**Financial Analysis**

### 1. Return Rate Comparison

* Cumulative return of TMO: 109.35%
* Cumulative return of VOO: 128.51%
* Divergence: -19.16 (simply the difference in cumulative return on the last day of the data)

The relative divergence is 29.60%, indicating the company is positioned near the top 29.60% of its past data.

### 2. Stock Price Fluctuations

* Recent stock price fluctuations: $623.91
* 5-day SMA: $630.45
* 20-day SMA: $613.70
* 60-day SMA: $588.22

The stock price has been trending downward, with the 60-day SMA being the lowest point.

### 3. RSI, PPO, and Delta_Previous_Relative_Divergence Analysis

* Market Risk Indicator (MRI): 0.70
* RSI: 51.60
* PPO: -0.02
* Expected Return (%): 48.90%

The current MRI indicates a medium-risk investment. The RSI and PPO indicators suggest a neutral market situation.

### 4. Recent News and Significant Events

Based on the provided news articles, several significant events and trends are emerging:

* Recent insider trading and hedge fund activity are being closely watched.
* The company's stock price is being compared to its peers, with some articles suggesting it may be undervalued.
* The company's growth expectations are being closely examined, particularly in the context of its recent earnings reports.

It is essential to monitor these developments closely to understand their potential impact on the company's stock price.

### 5. Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.54 (~Buy)
- Opinions: 23
- Target Price (avg/high/low): 652.61 / 750.00 / 575.00

The analyst consensus is overwhelmingly optimistic, with 23 opinions indicating a buy recommendation.

### 6. Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-31 | 4.28 | 11.12 B$ |
| 2025-08-01 | 4.28 | 10.86 B$ |
| 2025-05-02 | 3.99 | 10.36 B$ |
| 2024-11-01 | 4.26 | 10.60 B$ |
| 2025-10-31 | 4.26 | 10.60 B$ |

The recent earnings reports have been strong, with a consistent increase in revenue and a relatively stable earnings per share (EPS).

### 7. Comprehensive Analysis

Thermo Fisher Scientific Inc. has a strong financial foundation, with a growing revenue stream and a stable EPS. The company's stock price has been trending downward, but the recent earnings reports suggest a promising outlook. The analyst consensus is overwhelmingly optimistic, indicating a buy recommendation. However, the market risk indicator and other technical indicators suggest a medium-risk investment. It is essential to continue monitoring the company's financial performance and news developments to understand their potential impact on the stock price.

Recommendation:

* Short-term (1-3 months):
	+ Monitor the company's stock price fluctuations and respond accordingly.
	+ Keep a close eye on the recent news and events.
* Mid-term (6-12 months):
	+ Consider buying the stock if the current price is undervalued.
	+ Monitor the company's growth expectations and adjust the investment strategy accordingly.
* Long-term (1-2 years):
	+ Consider investing in the company based on its strong financial foundation and promising outlook.
	+ Monitor the company's financial performance and adjust the investment strategy accordingly.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.